Invention Grant
- Patent Title: Fusion proteins
- Patent Title (中): 融合蛋白
-
Application No.: US11853517Application Date: 2007-09-11
-
Publication No.: US08124405B2Publication Date: 2012-02-28
- Inventor: Keith Alan Foster , John Chaddock , Philip Marks , Patrick Stancombe , Lyndsey Durose
- Applicant: Keith Alan Foster , John Chaddock , Philip Marks , Patrick Stancombe , Lyndsey Durose
- Applicant Address: GB Abingdon, Oxfordshire
- Assignee: Syntaxin Limited
- Current Assignee: Syntaxin Limited
- Current Assignee Address: GB Abingdon, Oxfordshire
- Agency: Morris, Manning & Martin, LLP
- Agent Christopher W. Raimund
- Priority: GB0426397.6 20041201
- Main IPC: C07K14/00
- IPC: C07K14/00 ; C12N15/62 ; C12N15/63

Abstract:
The invention provides a single chain, polypeptide fusion protein, comprising: a non-cytotoxic protease, or a fragment thereof, which protease or protease fragment is capable of cleaving a protein of the exocytic fusion apparatus of a target cell; a Targeting Moiety that is capable of binding to a Binding Site on the target cell, which Binding Site is capable of undergoing endocytosis to be incorporated into an endosome within the target cell; a protease cleavage site at which site the fusion protein is cleavable by a protease, wherein the protease cleavage site is located between the non-cytotoxic protease or fragment thereof and the Targeting Moiety; and a translocation domain that is capable of translocating the protease or protease fragment from within an endosome, across the endosomal membrane and into the cytosol of the target cell.
Public/Granted literature
- US20080064092A1 FUSION PROTEINS Public/Granted day:2008-03-13
Information query